Education
About Us
Working with TipRanks
Follow Us
Marimed (TSE:MRMD)
:MRMD
MRMD Stock Chart & Stats
C$0.21
C$0.00(0.00%)
At close: 4:00 PM EST
C$0.21
C$0.00(0.00%)
Day’s Range― - ―
52-Week RangeC$0.06 - C$0.48
Previous CloseN/A
Volume0.00
Average Volume (3M)29.16K
Market Cap
C$58.23M
Enterprise ValueC$151.20M
Total Cash (Recent Filing)C$6.60M
Total Debt (Recent Filing)C$86.40M
Price to Earnings (P/E)―
Beta0.73
Next Earnings
Mar 11, 2026EPS Estimate
-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding395,073,640
10 Day Avg. Volume34,973
30 Day Avg. Volume29,162
Financial Highlights & Ratios
PEG Ratio0.13
Price to Book (P/B)0.71
Price to Sales (P/S)0.28
P/FCF Ratio-7.40
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$0.34Price Target Upside63.83% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
MariMed News
MRMD FAQ
What was Marimed’s price range in the past 12 months?
Marimed lowest stock price was C$0.06 and its highest was C$0.48 in the past 12 months.
What is Marimed’s market cap?
Marimed’s market cap is C$58.23M.
When is Marimed’s upcoming earnings report date?
Marimed’s upcoming earnings report date is Mar 11, 2026 which is in 85 days.
How were Marimed’s earnings last quarter?
Marimed released its earnings results on Nov 05, 2025. The company reported -C$0.014 earnings per share for the quarter, the consensus estimate of -C$0.014 by C$0.
Is Marimed overvalued?
According to Wall Street analysts Marimed’s price is currently Undervalued.
Does Marimed pay dividends?
Marimed does not currently pay dividends.
What is Marimed’s EPS estimate?
Marimed’s EPS estimate is -0.01.
How many shares outstanding does Marimed have?
Marimed has 395,073,640 shares outstanding.
What happened to Marimed’s price movement after its last earnings report?
Marimed reported an EPS of -C$0.014 in its last earnings report, expectations of -C$0.014. Following the earnings report the stock price went down -12.5%.
Which hedge fund is a major shareholder of Marimed?
Currently, no hedge funds are holding shares in TSE:MRMD
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
MariMed Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-18.93%
12-Months-Change
Fundamentals
Return on Equity
-28.43%
Trailing 12-Months
Asset Growth
-3.33%
Trailing 12-Months
Company Description
Marimed
MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company offers cannabis genetics produce flowers and concentrates under the Nature's Heritage brand; cannabis-infused products in the form of chewable tablets and powder drink mixes under the brand Kalm Fusion; natural fruit chews under the Betty's Eddies brand; brownies, cookies, and other social sweets under the Bubby's Baked brand; and cannabidiol formulations under the Florance brand. It also licenses its brands and product formulations, as well as leases cannabis facilities. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.
MRMD Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a mix of positive and negative aspects. MariMed reported sequential growth in revenue and positive cash flow, driven by strong performance in Delaware and strategic expansion into the hemp market. However, challenges in retail revenue, increased net losses, and exit from the Missouri market indicate ongoing industry pressures.View all TSE:MRMD earnings summariesMRMD Stock 12 Month Forecast
Average Price Target
C$0.34
▲(63.83% Upside)
Technical Analysis
cbdMD
―
Tilray
―
IM Cannabis Corp
―
Flora Growth
―
Incannex Healthcare Limited Sponsored ADR
―
Options Prices
Currently, No data available
---